Imaging metastatic bone disease from carcinoma of the prostate
about
Integrating circulating tumor cell data with imaging and serum prostate-specific antigen measurement for metastatic prostate cancer therapy managementCirculating tumor cells as biomarkers in prostate cancer.Metabolic flare phenomenon on 18 fluoride-fluorodeoxy glucose positron emission tomography-computed tomography scans in a patient with bilateral breast cancer treated with second-line chemotherapy and bevacizumab.Categorical versus continuous circulating tumor cell enumeration as early surrogate marker for therapy response and prognosis during docetaxel therapy in metastatic prostate cancer patientsBony metastases: assessing response to therapy with whole-body diffusion MRI.(18)F-fluoride positron emission tomography/computed tomography and bone scintigraphy for diagnosis of bone metastases in newly diagnosed, high-risk prostate cancer patients: study protocol for a multicentre, diagnostic test accuracy studyEpCAM Expression in Lymph Node and Bone Metastases of Prostate Carcinoma: A Pilot Study.Current approaches, challenges and future directions for monitoring treatment response in prostate cancer.Doping and musculoskeletal system: short-term and long-lasting effects of doping agents.Burden of metastatic bone disease from genitourinary malignancies.Imaging in prostate cancer staging: present role and future perspectives.Oncology imaging in the abdomen and pelvis: where cancer hides.MRI for response assessment in metastatic bone disease.False-positive diagnosis of disease progression by magnetic resonance imaging for response assessment in prostate cancer with bone metastases: A case report and review of the pitfalls of images in the literatureDetecting Tumor Metastases: The Road to Therapy Starts Here.Therapy assessment in prostate cancer using choline and PSMA PET/CT.Response in bone turnover markers during therapy predicts overall survival in patients with metastatic prostate cancer: analysis of three clinical trials.Investigation of computer-aided diagnosis system for bone scans: a retrospective analysis in 406 patients.Prospective evaluation of [11C]Choline PET/CT in therapy response assessment of standardized docetaxel first-line chemotherapy in patients with advanced castration refractory prostate cancer.[Imaging diagnostics of advanced prostate cancer].Clinical perspectives of PSMA PET/MRI for prostate cancer
P2860
Q30815486-46DEF27C-8E7F-485E-B33F-A9BF8720D7B3Q34193303-E811A2B0-ABB9-4F5A-9AB6-8CBB18E8D4A0Q35233066-E93C432C-7D67-460C-8EE2-F2224B1DAB5DQ35655761-DA0A2B23-BDD0-49BF-AAA3-CCFE59EAA3A3Q35697593-53C13188-22B8-41BB-A991-B3F09F42D4F2Q35890956-60DFDE80-4E96-4B77-879A-DB75737AE01DQ37377297-0EA491B9-7ED4-4E6C-B797-2E70EB3F4731Q37435181-320B1F79-8960-42BF-88A0-11868B48360EQ37805634-92E717ED-ED8A-42CF-BD41-9F69EDD65341Q37809860-94E5E01D-50CB-45CB-B4F0-CC20C953AA02Q37979650-CB19DE2E-D113-4025-8559-F830F339A7F6Q38033094-F160B97D-4DED-457B-AEE6-E92E5716A531Q38086042-C0CB6B3C-F51C-4F46-8072-BD63E25D007BQ38703685-32AFC615-B3B0-4D2E-AE8D-80EA750467F6Q38950545-C63B7CB7-C42C-412C-805D-7DA55B2E054AQ39328036-E3F9CD00-4CAE-4557-9653-4D40E47CDAD7Q41319701-A8DEF9BA-EBCF-41A3-B092-04215C23EC03Q51107932-641075FD-482A-49D2-B48F-3E6AE3EEC717Q52982270-CD72BB06-10D6-4F73-8E91-772D1A157F48Q53117553-FEA2D24D-6C8E-4701-B958-7907FBA30B73Q57071079-30B57320-3A41-4FB8-921A-FFDCBECA3D1D
P2860
Imaging metastatic bone disease from carcinoma of the prostate
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Imaging metastatic bone disease from carcinoma of the prostate
@en
Imaging metastatic bone disease from carcinoma of the prostate.
@nl
type
label
Imaging metastatic bone disease from carcinoma of the prostate
@en
Imaging metastatic bone disease from carcinoma of the prostate.
@nl
prefLabel
Imaging metastatic bone disease from carcinoma of the prostate
@en
Imaging metastatic bone disease from carcinoma of the prostate.
@nl
P2860
P356
P1476
Imaging metastatic bone disease from carcinoma of the prostate
@en
P2093
N M deSouza
P2860
P2888
P304
P356
10.1038/SJ.BJC.6605334
P407
P50
P577
2009-09-29T00:00:00Z